Human Milk Oligosaccharides (HMO) Market Growth, Business Prospect, Regional Overview| Forecast
Market Highlights
The Global Human Milk Oligosaccharides Market Szie
is Expected to Register a CAGR of 27.06% During
the Forecast Period with a market value of USD 110.03 Million in 2018.
The role of breast milk in infant nutrition is of paramount
importance as it ensures health and nourishment. However, in many cases,
breastfeeding is not an option due to factors such as genetic defects, terminal
diseases, and infections. In such cases, HMOs and associated functional foods
play an important role in providing the required nutrition and immunity. HMOs
play a major role in ensuring immunity more than nourishment. They are
undigested and thus act as preferred feed for the good bacteria in the gut.
This boosts the immune system, especially in infants, which helps fight viruses
and infectious bacteria.
Market Players
Market Research Future (MRFR) recognizes DuPont
Nutrition & Health (Denmark), Abbott (US), BASF SE (Germany), Glycom
(Denmark), Dextra Laboratories Limited (UK), Elicityl S.A. (France), Glycosyn
LLC (US), Inbiose (Belgium), Jennewein Biotechnologie GmbH (Germany), Medolac
Laboratories (US), Nestlé Health Science (Switzerland), and ZuChem (US) as
the key players in the global human milk oligosaccharides market.
Segment Analysis
The global human milk oligosaccharides industry is segmented
on the basis of type, application, and region.
Based on type, the global human milk oligosaccharides market
has been segregated into neutral and acidic. Application-wise, the market has
been segmented into food industry and laboratory research.
Browse Full Report Details @ https://www.marketresearchfuture.com/reports/human-milk-oligosaccharides-market-7843
Regional Analysis
The global human milk oligosaccharides market has been
segmented, on the basis of region, into North America, Europe, China, and
Japan.
North America accounted for the largest share of the global human
milk oligosaccharides (HMO) market growth in 2018 and is expected to
maintain its dominance throughout the forecast period. This can be attributed
to the high consumption of infant formula in the region and increasing approval
of new HMO products.
The European human milk oligosaccharides market was the
second largest in 2018. In the UK, the rate of breastfeeding is the
lowest in the world, which is a major determinant driving the regional market
growth. Moreover, the approval of new and enhanced HMOs in the region is also
contributing to the growth of the European human milk oligosaccharides market share.
China is expected to be the fastest-growing market for HMOs
during the forecast period owing to the increasing demand for HMO-based infant
formula in the country.
Key Findings of the Study
- The
global human milk oligosaccharides industry was valued at USD
110.03 million in 2018 and is expected to register a CAGR
of 27.06% during the forecast period.
- In 2018,
North America accounted for the largest share of the global market due to
the increasing consumption of infant formula.
- The
neutral segment accounted for the larger market share of 95% in
2018.
- The
food industry segment, by application, dominated the global human milk
oligosaccharides market with a share of 55% in 2018.
NOTE: Our Team of Researchers are Studying Covid19 and
its Impact on Various Industry Verticals and wherever required we will be
considering Covid19 Footprints for Better Analysis of Market and Industries.
Cordially get in Touch for More Details.
Contact us:
Market Research Future (part of Wantstats Research and
Media Private Limited),
Comments
Post a Comment